Let’s talk about everything LDN with the experts. Low-dose naltrexone (LDN) may be beneficial to your patients with stealth syndromes, autoimmune conditions, chronic diseases, and more.
Join Samantha Lebsock, PharmD, Belmar’s LDN expert and Vice President of Product Management, along with special guest, founder of the LDN Research Trust, Linda Elsegood to learn how LDN helps so many patients improve their quality of life.
This webinar is intended for providers. If you are a provider and would like to watch the webinar, please fill out the form below.
